Hillman Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.86M | Sell |
152,599
-12,544
| -8% | -$482K | 3.2% | 10 |
|
|
2025
Q1 | $6.4M | Sell |
165,143
-66,008
| -29% | -$2.56M | 3.15% | 8 |
|
|
2024
Q4 | $7.82M | Buy |
231,151
+34,255
| +17% | +$1.16M | 2.9% | 14 |
|
|
2024
Q3 | $8.05M | Buy |
196,896
+1,770
| +0.9% | +$72.4K | 2.76% | 16 |
|
|
2024
Q2 | $7.51M | Sell |
195,126
-38,360
| -16% | -$1.48M | 2.65% | 16 |
|
|
2024
Q1 | $10M | Buy |
233,486
+100
| +0% | +$4.29K | 3.22% | 6 |
|
|
2023
Q4 | $8.65M | Buy |
233,386
+522
| +0.2% | +$19.3K | 2.99% | 12 |
|
|
2023
Q3 | $8.44M | Sell |
232,864
-1,817
| -0.8% | -$65.9K | 3.25% | 5 |
|
|
2023
Q2 | $8.36M | Sell |
234,681
-2,735
| -1% | -$97.5K | 2.95% | 13 |
|
|
2023
Q1 | $8.45M | Sell |
237,416
-463
| -0.2% | -$16.5K | 3.2% | 8 |
|
|
2022
Q4 | $8.36M | Sell |
237,879
-6,099
| -2% | -$214K | 3.28% | 9 |
|
|
2022
Q3 | $7.18M | Buy |
243,978
+54,511
| +29% | +$1.6M | 2.98% | 11 |
|
|
2022
Q2 | $10.3M | Buy |
189,467
+916
| +0.5% | +$49.8K | 3.75% | 4 |
|
|
2022
Q1 | $10.3M | Buy |
188,551
+2,072
| +1% | +$113K | 3.26% | 2 |
|
|
2021
Q4 | $10.3M | Sell |
186,479
-6,942
| -4% | -$383K | 3.53% | 5 |
|
|
2021
Q3 | $9.24M | Buy |
193,421
+6,561
| +4% | +$313K | 3.24% | 12 |
|
|
2021
Q2 | $9.3M | Buy |
186,860
+1,208
| +0.7% | +$60.1K | 3.54% | 8 |
|
|
2021
Q1 | $8.28M | Buy |
185,652
+181,156
| +4,029% | +$8.08M | 3.63% | 6 |
|
|
2020
Q4 | $207K | Buy |
+4,496
| New | +$207K | 0.11% | 44 |
|